Current Therapeutics and Future Perspectives to Ocular Melanocytic Neoplasms in Dogs and Cats

por Guerra Guimarães, Tarcísio, Menezes Cardoso, Karla, Tralhão, Pedro, Marto, Carlos Miguel, Alexandre, Nuno, Botelho, Maria Filomena, Laranjo, Mafalda
Publicado 2021

Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro

por Martins, João, Elvas, Filipe, Brudzewsky, Dan, Martins, Tânia, Kolomiets, Bogdan, Tralhão, Pedro, Gøtzsche, Casper R., Cavadas, Cláudia, Castelo-Branco, Miguel, Woldbye, David P. D., Picaud, Serge, Santiago, Ana R., Ambrósio, António F.
Publicado 2015

Treatment with A(2A) receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage

por Boia, Raquel, Elvas, Filipe, Madeira, Maria H, Aires, Inês D, Rodrigues-Neves, Ana C, Tralhão, Pedro, Szabó, Eszter C, Baqi, Younis, Müller, Christa E, Tomé, Ângelo R, Cunha, Rodrigo A, Ambrósio, António F, Santiago, Ana R
Publicado 2017